Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
743 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Recruiting Perioperative Anticoagulant Use for Surgery Evaluation Study
Condition: Atrial Fibrillation
22 Unknown  Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
Conditions: Blood Coagulation Disorders;   Blood Coagulation Disorder With Prolonged Bleeding Time;   Blood Coagulation Disorder With Prolonged Coagulation Time
Interventions: Device: INR capillary measurement with INRatio 2 device;   Other: antiphospholipid antibodies and lupus anticoagulant
23 Not yet recruiting Pleotropic Effect of New Oral Anticoagulants
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran;   Drug: ribaroxaban;   Drug: Warfarin
24 Recruiting Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Conditions: Venous Thromboembolism;   Atrial Fibrillation
Intervention: Other: complications and compliance with GIHP recommendations
25 Not yet recruiting Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation: A Study of Clinical Characteristics With Insight From Patient and Physician Perspectives
Condition: Nonvalvular Atrial Fibrillation
26 Unknown  Reversal of the Antithrombotic Action of New Oral Anticoagulants
Conditions: Thrombosis;   Anticoagulant-induced Bleeding;   Anticoagulant Overdosage;   Hemorrhage
Interventions: Drug: Rivaroxaban;   Drug: Dabigatran
27 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
28 Unknown  Therapy With New Oral Anticoagulants
Conditions: Atrial Fibrillation;   Non-valvular Atrial Fibrillation
29 Not yet recruiting Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions
Conditions: Healthcare Quality Indicators;   Inappropriate Prescribing;   Anticoagulant Drugs;   Atrial Fibrillation;   Venous Thromboembolism;   Valvular Heart Disease;   Brain Injury
30 Unknown  D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Condition: Deep Venous Thrombosis
Interventions: Drug: Phenprocoumon;   Drug: Warfarin-Natrium
31 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
Condition: Non Valvular Atrial Fibrillation (nv AF)
Interventions: Drug: Non-exposed group;   Drug: Exposed group
32 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
33 Not yet recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
34 Recruiting Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Condition: Hematoma
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Apixaban
35 Unknown  Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
36 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
37 Recruiting Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
Conditions: Secondary Prevention;   Stroke;   Ischemic Heart Disease;   Coronary Heart Disease
Interventions: Drug: Acetylsalicylic Acid (Asprin, BAYE4465);   Drug: Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs
38 Not yet recruiting Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology
Condition: Atrial Fibrillation
Intervention: Other: Intervention
39 Not yet recruiting Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis
Conditions: Symptomatic Aortic Stenosis;   Eligible for Transcatheter Aortic Valve Replacement
Interventions: Drug: Apixaban;   Drug: Standard of care
40 Recruiting Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence
Conditions: Atrial Fibrillation;   Medication Adherence
Intervention: Other: Health Messaging (Non-Procedural)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years